www.scienceboard.org The Science Advisory Board - Protocols, Product Reviews, Member Forum, and Science News
Note: You are seeing this message either because your browser has not loaded our stylesheets, or because your browser does not support stylesheets (CSS). Please upgrade to a relatively modern browser to improve your experience. Not sure what to upgrade to? Try Firefox.
The Science Advisory Board
Screen Name: 
 
Password: 
 

Perspectives

only search SAB perspectives

Are you interested in submitting a Perspective Article? Be sure to read The Science Advisory Board's Editorial Guides for Perspective Articles. Click here.


The Evolution of Bioterrorism: The Agents Remain Constant but the Terrorist Profile Has Changed
by Mark Sorrentino, M.D., M.S.

Bioterrorism seems to be the current "buzz word." We have suddenly become inundated with comments by the so-called media "experts." What do we really know about bioterrorism? The FBI admitted in its 1997 annual "Terrorism in the United States" report that "there is no single, universally accepted definition of terrorism." We do know that bioterrorism has changed the nature of terrorism. Many bioterrorists have taken college-level courses in science related subjects, they are educated, and able to tackle the technological challenges of biological terrorism. As modern terrorist groups become decentralized and many self-declared terrorists work alone it has become increasingly difficult for law-enforcement agencies to counter effectively.

The CDC has ranked biological agents of concern to public health into three categories. Category A contains agents with the greatest threat in terms of their ability to cause mass morbidity and mortality. The diseases include smallpox (Variola major), anthrax (Bacillus anthracis), plague (Yersinia pestis), botulism (Clostridium botulinum), tularemia (Francisella tularensis), and hemorrhagic fevers (filoviruses/arenaviruses). Category B agents are considered to have potential for transmission/illness, but don't carry the same need for immediate public health action that the Category A agents have. They include Q fever (Coxiella burnetii), brucellosis (Brucella species), glanders (Burkholderia mallei), melsosdosis (Burkholderia pseudomallei), viral encephalitis (alphaviruses), typhus (Rickettsia prowazekii), toxin syndrome (toxins (ricin, Epsilon, toxin of Clostridium, perfringens, staphylococcal enterotoxin B)), psittacosis (Chlamydia psittaci), foodborne disease agents, waterborne disease agents. Finally, the Category C agents are those considered as possible emerging public health risks and include any agent identified by the CDC Emerging Infectious Disease Program such as hantavirus.

One can get detailed information about all of these agents from two excellent websites with public access that are dedicated to bioterrorism. Both of these are kept by Johns Hopkins University. The first can be found at http://www.hopkins-biodefense.org. Here you will find proceedings from bioterrorism symposia, educational materials, links to other sites of interest. In addition, go to http://www.hopkins-abxguide.org where you can search treatment options for a variety of infectious diseases by diagnosis, pathogen, or antibiotic.

Remember that in the event of a bioterrorism attack, first responders will be physicians, medical clinics, pubic health offices and emergency rooms. Awareness, education and preparedness are the keys to a successful response. A member of the Irish Republican Army once said, "You have to be lucky all the time -- we have to be lucky just once."

###

Mark Sorrentino, M.D., M.S.
MedImmune, Incorporated
SAB member since November 1998

###

<< Previous    Next >>   

[ View All Perspectives ]
Active Members
70,138

The Science Advisory Board is the world's original professional network of life scientists.

Members of the SAB:

  • Connect with other scientists.

  • Find tips, methodologies and procedures from established researchers.

  • Share insights, stories, jokes and even "gripes" in an open environment.

  • Voice opinions on companies and products used in their work.

  • Earn generous rewards for their opinions.

Practicing life science researchers and medical professionals participate in The Science Advisory Board's studies, forums, news articles and social media channels.